Extensive and multifaceted expertise in relevant fields

  • Industry executive and consultant in medical diagnostics, life sciences, biotechnology. and novel biomarkers.
  • Prior stock analyst for innovative medical products and firms.
  • Former McKinsey consultant.

LinkedIn Profile

Most read blogs on this site (links)

  1. A Myth about ROC Curves and C-statistics
  2. Qualitative Overview of Cardiac Biomarkers and Lab Services
  3. Biomarker Discovery and Development – Detailed Perspectives
  4. ROC c-statistic (AUCs) Subtlety that is Often Forgot
  5. Alzheimer’s Disease Biomarkers – Are In-vitro Diagnostics Really Needed?
  6. Heart Failure – Large Market Opportunities for New Biomarkers

Least read blogs (links)

  1. Barriers to Personalized Medicine and Companion Diagnostics
  2. Process to Divest Therapeutic Pipelines
  3. Perhaps Controversial – Why It’s Difficult to Make a Bus Dev Deal with an Established Company, and How to Solve This